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DBackground:Mitral valve replacement remains the last resort for treatment of congenital mitral valve disease.
Enlarging the mitral annulus at the time of mitral valve replacement may allow implantation of a larger prosthe-
sis in children.
Methods: All mitral valve replacement procedures from 1990 to 2012 were included, and mitral annulus
enlargement techniques were analyzed. A control group of patients undergoing replacement of a previously
implanted mechanical mitral valve prosthesis was compared with the cohort of patients who underwent annular
enlarging procedures. Primary end points were increases in annulus size and Z score, and freedom from paced
rhythm.
Results: Among 205 mitral valve replacement procedures, 16 (8%) included techniques to upsize the mitral
annulus in 15 patients, all but 1 of whom had undergone prior mitral valve replacement. These patients were
compared with a control cohort of 53 patients undergoing mitral valve re-replacement without annulus enlarge-
ment. The annulus was upsized by 18%  11% (compared with 16%  20% in controls, P ¼ .5) using open
balloon dilation in 4 patients, radial annular incisions in 5 patients, and patch augmentation of the aorto-mitral
continuity in 7 patients. The mean valvar diameter Z score increased from 0.2 1.3 toþ1.1 1.4 (P<.001),
compared with an increase from 0.3  1.2 to 0.9  1.1 in controls (P<.001). During a mean follow-up of
6.5  6.4 years, 4 of 12 patients required permanent pacing in the upsizing group (predominantly with patch
augmentation), versus 5 of 53 patients in the control group.
Conclusions: In children undergoing mitral valve replacement, various techniques can be used to upsize the
mitral annulus and allow implantation of a larger prosthesis. There is a nontrivial risk of heart block with annulus
upsizing, which deserves further study. (J Thorac Cardiovasc Surg 2013;146:347-51)Video clip is available online.
Mitral valve replacement (MVR) remains the last resort for
treatment of congenital mitral valve disease in children, and
it is especially challenging in infants with congenital mitral
disease because of the small size of the native valve annulus,
left atrium, and ventricle that predisposes them to complica-
tions related to leaflet entrapment, left ventricular outflow
tract or pulmonary venous obstruction, and heart block.1
Anymitral prosthesis placed in a child obligates reoperation
to adjust for somatic growth, often prompting placement of
as large a prosthesis as possible to delay patient–prosthesis
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The Journal of Thoracic and Caavailable mechanical prostheses are substantially over-
sized; supra-annular implant has been used to accommodate
such mismatch, but this approach can be problematic for
a number of reasons.3,4 Furthermore, an increased ratio of
prosthetic valve size to patient weight was shown to be an
independent age-adjusted predictor of death in the Pediatric
Cardiac Care consortium report.5
Enlargement of a hypoplastic aortic annulus has been de-
scribed with good results6-8; however, there are few reports
of augmenting the mitral annulus.9We report the techniques
and outcomes of mitral annulus–enlarging procedures in
children undergoing MVR over a 22-year period.MATERIALS AND METHODS
Study Design
We reviewed all patients who underwent MVR between January 1990
and January 2012 at Children’s Hospital Boston&HarvardMedical School
by using a query of the cardiac surgery and cardiology databases. Operative
notes were reviewed for techniques aimed at increasing the size of the mi-
tral annulus. The study was approved by the Children’s Hospital Institu-
tional Review Board, and individual patient consent was waived. A
control group of patients who underwent mitral valve re-replacement
(reMVR) without annulus-enlarging procedures was used for comparison
of baseline characteristics and outcomes.
The primary outcome measures were operative mortality, annulus size,
and Z score increase and freedom from paced rhythm at latest follow-up.
Secondary end points included valve-related complications, reoperations,rdiovascular Surgery c Volume 146, Number 2 347
Abbreviations and Acronyms
MVR ¼ mitral valve replacement
reMVR ¼ mitral valve re-replacement
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Dand late mortality. Clinical or treatment variables were recorded to deter-
mine predictors of the end points. Because all measurements except for 1
involved a prosthetic valve, making echocardiographic measurements dif-
ficult, the prosthesis manufacturer-rated sizes for the prosthesis being re-
moved and the prosthesis that was placed were used as approximations
of mitral annular diameter before and after MVR, because measures of
the mitral annulus were not systematically recorded in the operative notes.
Z scores based on these measurements were calculated using normative
equations for the mitral valve lateral diameter.
Statistical Analysis
Statistical analyses were performed with the Statistical Package for the
Social Sciences (v 19, SPSS Inc, Chicago, Ill). Data are presented as
mean  standard deviation. Continuous variables were analyzed with the
Student t test or the Wilcoxon signed-rank test when appropriate, and cat-
egoric variables were analyzed using the chi-square test or Fisher exact test
when appropriate. Freedom from paced rhythm was calculated using the
Kaplan–Meier method, and differences between curves were assessed by
the log-rank test. Patients who were paced before the MVR operation in-
cluded in the study were excluded from freedom from paced rhythm sur-
vival analysis. Data are presented as mean  standard deviation, median
(minimum-maximum), or frequency (%).RESULTS
Demographics
Among 205MVR procedures performed during the study
period, 16 (8%) in 15 patients included additional techniques
to upsize the mitral annulus to accommodate placement of
a larger prosthesis. All but 1 of these patients had undergone
prior MVR, and all had some form of mitral valve repair per-
formed beforeMVR.A control group comprising 53 patients
undergoing reMVRwithout annulus upsizing was compared
with the study cohort. Patient baseline characteristics in the
study and control groups are illustrated in Table 1.Amajority
of the patients had hypoplastic left heart structures, varying
from hypoplastic left heart syndrome, Shone’s complex,
and unbalanced atrioventricular canal defects to congenital
mitral stenosis. There were no statistically significant differ-
ences between the baseline characteristics in the study group
and the controls. One of the patients who underwent mitral
annulus augmentation was reported previously.9 All patients
received a mechanical prosthesis (mostly from St Jude Med-
ical Inc, St Paul,Minn), with the exception of 2 who received
a bioprosthetic valve (1 each in the study and control groups,
a Hancock valve [Medtronic, Minneapolis, Minn] and
a Melody valve [Medtronic], respectively).Mitral Annulus Upsizing
In the annular upsizing group, the annulus was increased
from a median diameter of 19 mm (12-23 mm; mean,348 The Journal of Thoracic and Cardiovascular Surg18.8  2.5 mm) to 22 mm (16-27 mm; mean,
22.1  3 mm, P < .001) and a mean Z score of
0.16  1.28 to þ1.12  1.42 (P< .001). The decision
to perform additional procedures for annulus upsizing was
based on the surgeon’s intraoperative decision to permit im-
plantation of a larger prosthesis compared with the one be-
ing explanted. The mean annular dimensions before and
after MVR are summarized in Table 2; annular upsizing
was performed using open balloon dilation with or without
radial incisions in the annulus in 4 patients (techniques
detailed in Table 3; see Video 1 for illustration of the
technique), 5 patients had radial annular incisions without
additional annulus-enlarging procedures, and 6 patients
had patch augmentation of the aorto-mitral continuity in 7
operations, following Nicks’ technique in 1, Manougian
technique in 2, and modified Manougian technique9 in 4.
The changes in valve diameter and Z score did not differ sig-
nificantly between annulus-upsizing techniques.
In the control group, the annulus was upsized at reMVR
from amedian of 19 mm (16-31 mm; mean, 20.1 3.4 mm)
to 23 mm (16-35 mm; mean, 23.5  3.6 mm, P< .001),
which was an increase in the Z score from 0.31  1.17
to þ0.94  1.13 (P<.001). There were no significant dif-
ferences in final valve diameter or Z score between the an-
nulus upsizing and control groups (P ¼ .6 and P ¼ .1,
respectively).
Outcomes
There were 2 operative deaths due to severe left ventric-
ular failure after mitral and aortic valve replacement with
Manougian annulus augmentation, which were both in the
early period of the study (1990 and 1991). The postmortem
examination found well-functioning prostheses and intact
coronaries in 1 patient, and a paravalvar mitral leak and
proximal right coronary artery occlusion by an aortic valve
prosthesis leaflet stuck in the open position in 1 patient.
There were no other ischemic, bleeding, or thromboembolic
complications due to these additional procedures.
During a mean follow-up of 6.5 6.4 years, 4 patients in
the annulus upsizing group and 5 patients in the control
group required new permanent pacemaker implantation.
As shown in Figure 1, freedom from a new paced rhythm
after MVR (ie, excluding patients with existing pace-
makers) was 86% 10% at 1 year, 73% 14% at 3 years,
and 59%  17% at 5 years in the annulus upsizing group,
compared with 88%  5% at 1, 5, and 10 years in the con-
trol group (P¼ .15). One patient who underwent both radial
annular incisions and balloon dilation developed postoper-
ative complete heart block and required transvenous pace-
maker implantation 10 days after MVR. This patient
returned to normal sinus rhythm by 3 months postopera-
tively and was no longer in a paced rhythm at most recent
follow-up (4 months after MVR). Acute postoperative com-
plete heart block developed in 4 patients with anteriorery c August 2013
TABLE 1. Baseline characteristics of study patients and controls
Annulus
upsizing
group
(n ¼ 16)
reMVR
controls
(n ¼ 53) P
Age (y) 10.8  6.2 14.1  9.2 .1
BSA (m2) 0.97  0.38 1.16  0.44 .1
Male 10 (63%) 28 (53%) .6
Reason for MVR
Shone’s complex 5 (31%) 11 (21%) .5
Congenital mitral stenosis 4 (25%) 15 (28%) 1
Common atrioventricular
canal defect
4 (25%) 21 (40%) .4
Borderline hypoplastic left
heart syndrome
1 (6%) 0 (0%) .2
Endocarditis 1 (6%) 1 (2%) .4
Other 1 (6%) 5 (9%) 1
Prior procedures
Mitral balloon valvuloplasty 0 (0%) 7 (13%) .2
Surgical mitral valvuloplasty 10 (63%) 19 (36%) .08
MVR 15 (94%) 53 (100%) .2
reMVR 3 (19%) 23 (43%) .09
Fetal aortic balloon
valvuloplasty
1 (6%) 0 (0%) .2
Aortic balloon valvuloplasty 1 (6%) 4 (8%) 1
Aortic valve repair 2 (13%) 5 (9%) .7
Aortic valve replacement 2 (13%) 1 (2%) .1
Atrioventricular canal defect
repair
4 (25%) 21 (40%) .4
Left ventricular EFE resection 1 (6%) 0 (%) .2
Subaortic stenosis repair 6 (38%) 15 (28%) .5
Coarctation repair 4 (25%) 12 (23%) 1
Permanent pacemaker
implantation
1 (6%) 11 (21%) .2
Other procedures 6 (38%) 21 (40%) 1
Native mitral annulus diameter
(mm)
18.8  2.5 20.1  3.4 .1
Native mitral annulus diameter
Z score
0.16  1.28 0.29  1.16 .7
All values are reported as mean  standard deviation or number (percentage) unless
otherwise indicated. reMVR, Mitral valve re-replacement; BSA, body surface area;
MVR, mitral valve replacement; EFE, endocardial fibroelastosis.
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Dannulus patch augmentation; 2 were the operative deaths
mentioned earlier and 2 underwent pacemaker implantation
6 and 8 days after MVR, respectively. One patient who un-
derwent annulus enlargement with radial annular incisionsTABLE 2. Mitral annulus–upsizing techniques and results
Technique N
Native annulus
diameter (mm) Z score
Balloon dilatation þ/ radial
annular incisions
4 18  4.2 0.39  0.43
Radial annular incisions 5 18.8  1.5 0.15  2.1
Aorto-mitral continuity patch
augmentation
7 19.1  2.2 0.03  0.98
All values are reported as mean  standard deviation or number (percentage) unless othe
The Journal of Thoracic and Cahad first-degree atrioventricular block in the immediate
postoperative period, but this progressed to complete heart
block by 2.8 years postoperatively, at which point transve-
nous pacemaker implantation was performed.
Two patients in the study group underwent an additional
reMVR, both in conjunction with aortic valve replacement.
One of these patients underwent Manougian mitral annulus
augmentation at the time of redoMVR, and the other did not
have further annulus augmentation. There was 1 noncardiac
late death, and 1 patient died of perioperative stroke after
a reoperation for aortic valve replacement and reMVR.DISCUSSION
MVR in children remains a last resort to a difficult prob-
lem. In children with a small or hypoplastic native mitral
annulus, implantation of commercially available prosthetic
valves can be problematic. Supra-annular prosthesis im-
plantation has been proposed when annular implantation
is not possible, but early results have been discouraging,
with high mortality and the risk of left atrial diastolic dys-
function and pulmonary vein stenosis,10-12 although more
recent reports have shown good results.4 Furthermore,
supra-annular MVR does not protect against leaflet entrap-
ment or valve thrombosis, which occurred in 13% of the pa-
tients with supra-annular MVR reported by Kanter and
colleagues.4
In some children, even supra-annular implantation does
not allow placement of a large enough prosthesis. Much
as with aortic valve replacement in a small aortic root, the
options in this situation are to place a smaller prosthesis,
risking earlier patient–prosthesis mismatch, or to increase
the size of the native mitral annulus.6-8 Methods of
increasing the size of the native mitral annulus have been
seldom reported,9 because at the time of reMVR, the pros-
thesis usually can be upsized by 2 sizes on average.13
In our experience with MVR, 8% of procedures have in-
cluded a technique to upsize the mitral annulus at MVR to
permit upsizing of the new prosthesis. This has included
a variety of techniques, including intraoperative balloon
dilation of the annulus under direct vision, radial annular
incisions, and patch augmentation of the aorto-mitral conti-
nuity. By using these techniques, it was possible to enlarge
the annulus by approximately 2 mm on average and to placeFinal annulus
diameter (mm) Z score
Mitral annulus
diameter increase
Z score
increase
21.3  4.8 0.96  0.82 19.3%  13.8% 1.36  1.1
23  3.2 1.3  2.1 22.1%  11.7% 1.41  0.42
21.9  2.0 1.11  1.30 14.6%  7.7% 1.13  0.60
rwise indicated.
rdiovascular Surgery c Volume 146, Number 2 349
TABLE 3. Intraoperative balloon dilation for enlarging the mitral
annulus
Technique
Native
annulus
diameter
(mm)
Z
score
Final
annulus
diameter
(mm)
Z
score
Increase
in mitral
annulus
diameter (%)
Radial annular
incisions, 22-mm
balloon at 12 and
30 Atm
21 0.47 23 0.16 10%
Radial annular
incisions, 18-mm
high-pressure
balloon
18 0.09 19 0.36 6%
26-mm balloon
at 4 Atm
21 0.25 27 1.76 29%
14-mm balloon
at 4 Atm, 16 mm
balloon at 2 Atm
12 0.94 16 1.59 33%
Atm, Atmospheres.
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Da prosthesis of similar size in patients undergoing reMVR
who did not require annulus enlargement.
More patients in the annulus upsizing group required per-
manent pacing than in the reMVR group, although thisFIGURE 1. Kaplan–Meier analysis of freedom from paced rhythm, com-
paring the annulus upsizing group with the reMVR group. Twelve patients
were excluded from the freedom from paced rhythm survival analysis
because of prior pacemaker insertion, 1 (6%) in the annulus upsizing group
and 11 (21%) in the reMVR group. MVR, Mitral valve replacement;
reMVR, mitral valve re-replacement.
350 The Journal of Thoracic and Cardiovascular Surgdifference did not reach statistical significance. The preva-
lence of postoperative heart block or pacemaker implanta-
tion is nontrivial after MVR in children, ranging from 6%
to 33%.1,3,14 Supra-annular implantation has not been
proven to protect from pacemaker requirement, with a re-
ported prevalence of pacemaker implantation after primary
supra-annular MVR of 21%4 and additional risk at the time
of the inevitable reMVR.3 In our experience with annulus
upsizing at MVR, 4 patients required new pacemaker
implantation and long-term pacing, including 3 who under-
went a Manougian patch augmentation of the aorto-mitral
continuity and 1 who underwent radial annular incisions,
and none who underwent intraoperative balloon dilation.
Although the difference in this outcome between techniques
was not significant, given the limited number of patients, all
but 1 of the patients with long-term pacing underwent
a Manougian annulus augmentation. This technique in-
volves a Guiraudon-type superior trans-septal approach to
the mitral valve, which requires division of the sinus node
artery and anterior internodal pathway, and depending on
the location of the atriotomy and septal incision may also
place the middle and posterior internodal pathways at
risk.15Study Limitations
This study has several limitations. It is a retrospective and
nonrandomized comparison of techniques to upsize the mi-
tral annulus and represents a 22-year period of evolving
experience with MVR. As such, any inferences drawn
from these data are limited by confounding variables that
are differently distributed between study groups, such as
associated lesions, degree of hypoplasia of the left heart
structures, and duration of follow-up. Given the long study
period, there is the potential for changes in management
practices. Our sample size also limits our ability to perform
extensive statistical adjustments for these differences. The
choice to use an annulus-upsizing technique was at the dis-
cretion of the operating surgeon, as was the specific tech-
nique used, introducing the risk of selection bias. We have
no control group of patients in whom the annulus was not
upsized and a smaller prosthesis was placed. Nonetheless,
this represents the largest series of annulus-upsizing proce-
dures and analyzes the specific risk of permanent pacing
after such procedures.CONCLUSIONS
AfterMVR in childhood, it has been reported that a mitral
prosthesis can be upsized by an average of 2 sizes at the time
of re-replacement.2,3,13 As illustrated in this report,
additional techniques can be used successfully to upsize
an annulus that is hypoplastic because of the intrinsic
disease or inadequate growth, but such procedures carry
a nontrivial risk of heart block. These techniques shouldery c August 2013
Myers et al Congenital Heart Diseasebe considered as an additional surgical tool for MVR in
children.C
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